Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading
- 31 October 2000
- journal article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 38 (2), 101-107
- https://doi.org/10.1016/s0732-8893(00)00177-2
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patientsJournal of Antimicrobial Chemotherapy, 1999
- Comparative in Vitro Activity of Voriconazole and Itraconazole Against Fluconazole-Susceptible and Fluconazole-Resistant Clinical Isolates of Candida Species from SpainEuropean Journal of Clinical Microbiology & Infectious Diseases, 1999
- Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.Clinical Infectious Diseases, 1998
- Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patientsMycoses, 1997
- Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida speciesAntimicrobial Agents and Chemotherapy, 1997
- Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungiAntimicrobial Agents and Chemotherapy, 1995
- Fluconazole-Resistant Candida albicansClinical Infectious Diseases, 1993
- Azole Antifungal AgentsClinical Infectious Diseases, 1992
- Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of readingAntimicrobial Agents and Chemotherapy, 1991
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990